- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Faculty Research and Publications /
- Are antidepressants safe in pregnancy? A focus on SSRIs
Open Collections
UBC Faculty Research and Publications
Are antidepressants safe in pregnancy? A focus on SSRIs Therapeutics Initiative (University of British Columbia)
Description
Therapeutics Letter 76 reviews the harms and benefits of selective serotonin reuptake inhibitors (SSRIs) in pregnancy. Conclusions and clinical implications: There is no evidence that SSRIs in pregnancy improve maternal or infant health, and substantive evidence that they pose a risk to the fetus. Thus the harms exceed the benefits in this setting. Non-drug options such as cognitive behavioural therapy or psychotherapy are also unproven, but do not carry a risk to the fetus. The common argument of their lack of availability is not relevant for this relatively small, high priority population. If a patient wants to stop SSRIs in pregnancy, it is best to taper the dose over at least 1 week to minimize withdrawal symptoms. Exercise, social support, sleep hygiene and good nutrition are important for all pregnant people, including those with symptoms of depression.
Item Metadata
Title |
Are antidepressants safe in pregnancy? A focus on SSRIs
|
Alternate Title |
Therapeutics Letter 76
|
Creator | |
Date Issued |
2010-02
|
Description |
Therapeutics Letter 76 reviews the harms and benefits of selective serotonin reuptake inhibitors (SSRIs) in pregnancy. Conclusions and clinical implications: There is no evidence that SSRIs in pregnancy improve maternal or infant health, and substantive evidence that they pose a risk to the fetus. Thus the harms exceed the benefits in this setting. Non-drug options such as cognitive behavioural therapy or psychotherapy are also unproven, but do not carry a risk to the fetus. The common argument of their lack of availability is not relevant for this relatively small, high priority population. If a patient wants to stop SSRIs in pregnancy, it is best to taper the dose over at least 1 week to minimize withdrawal symptoms. Exercise, social support, sleep hygiene and good nutrition are important for all pregnant people, including those with symptoms of depression.
|
Subject | |
Genre | |
Type | |
Language |
eng
|
Notes |
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
|
Date Available |
2023-06-20
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivatives 4.0 International
|
DOI |
10.14288/1.0433655
|
URI | |
Affiliation | |
Peer Review Status |
Reviewed
|
Scholarly Level |
Faculty; Researcher
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International